| Literature DB >> 26357671 |
Hironaga Satake1, Tomonori Yano1, Yusuke Yoda1, Satoshi Fujii2, Sadatomo Zenda3, Toshifumi Tomioka4, Takeshi Shinozaki4, Masakazu Miyazaki4, Kazuhiro Kaneko1, Ryuichi Hayashi4.
Abstract
BACKGROUND AND STUDY AIMS: Local failure after radiation therapy for pharyngeal squamous cell carcinoma (PSCC) is problematic. The safety of endoscopic resection for lesions within the radiation therapy (RT) field has not been assessed. We evaluated salvage endoscopic resection in patients with locoregional failure after definitive radiotherapy for PSCC. PATIENTS AND METHODS: We retrospectively evaluated the clinical outcomes and long-term survival of 16 patients initially treated with more than 60 Gy of radiation for PSCC. These patients later presented with 19 superficial metachronous or recurrent PSCC lesions within the radiation field and were treated with salvage endoscopic resection.Entities:
Year: 2015 PMID: 26357671 PMCID: PMC4554502 DOI: 10.1055/s-0034-1392093
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1Salvage endoscopic submucosal dissection with a DualKnife in a patient with locoregional failure after definitive radiotherapy for pharyngeal cancer. a Endoscopy with white light shows a reddish, flat lesion of the left aryepiglottic fold against the background of the white color of the edematous piriform sinus. b Endoscopy with narrow-band imaging shows a brownish neoplastic area. c Chromoendoscopy with 2.0 % iodine staining to demarcate the lesion. d Marking around the lesion with a DualKnife. e An adequate volume of 0.9 % saline solution mixed with a low volume of epinephrine (0.02 mg/mL) is injected into the subepithelial layer beneath the lesion. f Circumferential incision made with a DualKnife. g Induced ulcer after removal of the lesion.
Patient characteristics (n = 163).
| Post-RT salvage (n = 16) | Non-RT (n = 147) |
| |
| Median age (range), y | 66 (52 – 80) | 64 (42 – 88) | 0.180 |
| Male / female, n (%) | 16/0 (100/0) | 143/4 (97/3) | 0.505 |
| Multiple Lugol-voiding lesions, n (%) | |||
| Positive | 11 (69) | 124 (84) | |
| Negative | 4 (25) | 19 (13) | 0.385 |
| Unknown | 1 (6) | 4 (3) | |
| Primary site of prior lesion, n (%) | |||
| Oropharynx | 5 (31) | ||
| Hypopharynx | 3 (19) | ||
| Larynx | 8 (50) | ||
| Median total dose of RT (range), Gy | 66 (60 – 76.8) | ||
| CR to definitive RT, n (%) 16 (100) | |||
RT, radiotherapy; CR, complete response.
Lesion characteristics (n = 203).
| Post-RT salvage (n = 22) | Non-RT (n = 181) |
| |
| Median lesion size (range), mm | 15 (4 – 50) | 15 (2 – 50) | 0.980 |
| Macroscopic type, n (%) | 0.044 | ||
| 0-I | 2 (9) | 5 (3) | |
| 0-IIa | 9 (41) | 49 (27) | |
| 0-IIb | 9 (41) | 96 (53) | |
| 0-IIc | 2 (9) | 31 (17) | |
| Location, n (%) | 0.013 | ||
| Hypopharynx | 16 (73) | 155 (86) | |
| Piriform sinus | 10 (45) | 128 (71) | |
| Posterior wall | 3 (14) | 16 (9) | |
| Post-cricoid area | 3 (14) | 11 (6) | |
| Orophaynx | 6 (27) | 26 (14) | |
| Posterior wall | 2 (9) | 15 (8) | |
| Lateral wall | 0 (0) | 3 (2) | |
| Vallecula | 2 (9) | 6 (3) | |
| Uvula | 1 (5) | 0 (0) | |
| Tonsil | 1 (5) | 2 (1) |
RT, radiotherapy; 0-I, protruded type; 0-IIa, slightly elevated type; 0-IIb, flat type; 0-IIc, slightly depressed type.
Clinical results of endoscopic resection procedures (n = 203).
| Post-RT salvage (n = 22) | Non-RT (n = 181) |
| |
| Endoscopic resection method, n (%) | 0.463 | ||
| EMR-C | 16 (73) | 119 (66) | |
| ESD | 6 (27) | 56 (31) | |
| ELPS | 0 (0) | 6 (3) | |
| Mean procedure time (SD), min | 70 (40) | 61 (41) | 0.809 |
| Endoscopic resection type, n (%) | 0.324 | ||
| En bloc | 17 (77) | 121 (67) | |
| Piecemeal | 5 (23) | 60 (33) | |
| Median number of resected segments (range) | 3 (2 – 9) | 3 (2 – 11) | |
| Median NPO duration after endoscopic resection (range), d | 2 (1 – 10) | 2 (1 – 20) | 0.131 |
| Median length of hospital stay after endoscopic resection (range), d | 9 (4 – 58) | 8 (3 – 53) | 0.154 |
RT, radiotherapy; EMR-C, endoscopic mucosal resection with cap-equipped pan-endoscope; ESD, endoscopic subepithelial dissection; ELPS, endoscopic laryngopharyngeal surgery; SD, standard deviation; NPO, nil per os (nothing by mouth).
Complications associated with endoscopic resection procedures (n = 163).
| Post-RT salvage (n = 16) | Non-RT (n = 147) |
| |
| Major complications, n (%) | 1 (6) | 17 (12) | 0.912 |
| Aspiration pneumonia | 1 | 4 | |
| Subcutaneous emphysema | 0 | 4 | |
| Delayed bleeding | 0 | 3 | |
| Facial edema | 0 | 1 | |
| Fever | 0 | 1 | |
| Laryngeal edema | 0 | 2 | |
| Difficult hemostasis | 0 | 1 | |
| Delirium | 0 | 1 | |
| Temporary tracheostomy, n (%) | 3 (19) | 28 (19) | 0.977 |
RT, radiotherapy.
Results of pathologic examination of endoscopic resection specimens (n = 203).
| Post-RT salvage (n = 22) | Non-RT (n = 181) |
| |
| Depth of invasion, n (%) | 0.235 | ||
| EP | 17 (77) | 123 (68) | |
| SEP | 4 (18) | 55 (30) | |
| Nonmalignant | 1 (5) | 3 (2) | |
| Lymphatic invasion, n (%) | 0.621 | ||
| Present | 0 (0) | 2 (1) | |
| Absent | 22 (100) | 179 (99) | |
| Venous invasion, n (%) | 0.190 | ||
| Present | 2 (9) | 6 (3) | |
| Absent | 20 (91) | 175 (97) | |
| Lateral margin of specimen, n (%) | 0.687 | ||
| Negative | 6 (27) | 65 (36) | |
| Positive | 7 (32) | 46 (25) | |
| Difficult evaluation | 9 (41) | 70 (39) | |
| Vertical margin of specimen, n (%) | 0.105 | ||
| Negative | 18 (82) | 160 (88) | |
| Positive | 2 (9) | 3 (2) | |
| Difficult evaluation | 2 (9) | 18 (10) | |
| Pathologic T stage, n (%) | 0.705 | ||
| T1 | 17 (77) | 138 (76) | |
| T2 | 4 (18) | 38 (21) | |
| T3 | 0 (0) | 2 (1) | |
| T4 | 0 (0) | 0 (0) | |
RT, radiotherapy; EP, epithelial; SEP, subepithelial.
Clinical course after endoscopic resection (n = 163).
| Post-RT salvage (n = 16) | Non-RT (n = 147) |
| ||
| Local failure, n (%) | 2 (13) | 10 (7) | 0.409 | |
| Treatment | Repeat endoscopic resection | 2 | 8 | |
| Partial resection | 0 | 1 | ||
| No treatment | 0 | 1 | ||
| Neck lymph node metastasis | 1 (6) | 2 (1) | 0.168 | |
| Treatment | Neck lymph node dissection | 1 | 0 | |
| Chemoradiotherapy | 0 | 1 | ||
| No treatment | 0 | 1 | ||
| Cause of death, n | ||||
| Esophageal squamous cell carcinoma | 1 | 8 | ||
| Head and neck carcinoma | 2 | 5 | 0.796 | |
| Other | 0 | 9 | ||
| Unknown | 2 | 4 | ||
RT, radiotherapy.
Congestive heart failure (n = 2), lung cancer (n = 2), cerebral infarction (n = 1), cholangiocarcinoma (n = 1), colon cancer (n = 1), gastric cancer (n = 1), pancreatic cancer (n = 1).
Fig. 2Overall survival time after salvage endoscopic resection.
Historical comparison of salvage endoscopic resection and other treatments.
| Post-RT salvage endoscopic resection (n = 16) | Post-RT salvage TLM (n = 62) | Post-RT salvage surgery (n = 30) | |
| Median age, y | 64 | 65 – 67 | 57 |
| Prior lesion TNM stage before RT, % | |||
| I | 6 | 20 | 0 |
| II | 19 | 38 | 23 |
| III | 6 | 30 | 27 |
| IV | 25 | 6 | 50 |
| Invalid | 44 | 6 | 0 |
| TNM stage I – II, % | 95 | 62 | NE |
| Patients with 3-year overall survival, % | 68.3 | 52 | 55 |
| Complications, % | 6 | 16 | 40 |
| Failure patterns | |||
| Local, % | 13 | NE | 37 |
| Nodal, % | 6 | NE | 10 |
RT, radiotherapy; TLM, transoral laser microsurgery; TNM, tumor node metastasis; NE, not evaluated.
Invalid because primary tumor and regional lymph nodes could not be assessed (TX and NX).